Therapeutic aspects of stem cells in regenerative medicine

Alok Mishra, Mukesh Verma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Regenerative medicine is the process of replacing or regenerating human cells, tissues, or organs and establishing normal function. In the last 20 years "stem cell research" has made significant advancement of their fundamental understanding of therapeutic intervention. The different kinds of organ-specific, embryonic, and induced pluripotent stem cells-based therapies offer potentially very strong and promising treatment regimens for contemporary and future medicine. Some of them are even approved and legalized for medical practice by the regulatory bodies of health research, such as US Food and Drug Administration. In the present review, we have compiled the overview of some of the stem cell-based therapies, which are widely linked to important human diseases. Our major aim is to sensitize the readers precisely about therapeutic potentials and application in precision medicine of different kinds of stem cells in disease-specific manner rather than providing the details of the fundamentals of signaling pathways and molecular biology involved in identification and propagation. We have also discussed about the clinically relevant stem cells implicated in regenerative medicine and finally cancer stem cells. The medicolegal issues are also discussed in this chapter.

Original languageEnglish (US)
Title of host publicationEmerging Fields, Animal and Medical Biotechnologies
PublisherElsevier Inc.
Pages497-505
Number of pages9
Volume1
ISBN (Electronic)9780128047491
ISBN (Print)9780128046593
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Regenerative Medicine
Stem cells
Stem Cells
Cell- and Tissue-Based Therapy
Stem Cell Research
Induced Pluripotent Stem Cells
Precision Medicine
Neoplastic Stem Cells
United States Food and Drug Administration
Medicine
Molecular Biology
Therapeutics
Molecular biology
Bioelectric potentials
Health
Research
Cells
Tissue

Keywords

  • Biomarker
  • Pluripotent cells
  • Regenerative medicine
  • Stem cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mishra, A., & Verma, M. (2017). Therapeutic aspects of stem cells in regenerative medicine. In Emerging Fields, Animal and Medical Biotechnologies (Vol. 1, pp. 497-505). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-804659-3.00021-X

Therapeutic aspects of stem cells in regenerative medicine. / Mishra, Alok; Verma, Mukesh.

Emerging Fields, Animal and Medical Biotechnologies. Vol. 1 Elsevier Inc., 2017. p. 497-505.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mishra, A & Verma, M 2017, Therapeutic aspects of stem cells in regenerative medicine. in Emerging Fields, Animal and Medical Biotechnologies. vol. 1, Elsevier Inc., pp. 497-505. https://doi.org/10.1016/B978-0-12-804659-3.00021-X
Mishra A, Verma M. Therapeutic aspects of stem cells in regenerative medicine. In Emerging Fields, Animal and Medical Biotechnologies. Vol. 1. Elsevier Inc. 2017. p. 497-505 https://doi.org/10.1016/B978-0-12-804659-3.00021-X
Mishra, Alok ; Verma, Mukesh. / Therapeutic aspects of stem cells in regenerative medicine. Emerging Fields, Animal and Medical Biotechnologies. Vol. 1 Elsevier Inc., 2017. pp. 497-505
@inbook{610917389fe44669bd61cf9f4e3194b0,
title = "Therapeutic aspects of stem cells in regenerative medicine",
abstract = "Regenerative medicine is the process of replacing or regenerating human cells, tissues, or organs and establishing normal function. In the last 20 years {"}stem cell research{"} has made significant advancement of their fundamental understanding of therapeutic intervention. The different kinds of organ-specific, embryonic, and induced pluripotent stem cells-based therapies offer potentially very strong and promising treatment regimens for contemporary and future medicine. Some of them are even approved and legalized for medical practice by the regulatory bodies of health research, such as US Food and Drug Administration. In the present review, we have compiled the overview of some of the stem cell-based therapies, which are widely linked to important human diseases. Our major aim is to sensitize the readers precisely about therapeutic potentials and application in precision medicine of different kinds of stem cells in disease-specific manner rather than providing the details of the fundamentals of signaling pathways and molecular biology involved in identification and propagation. We have also discussed about the clinically relevant stem cells implicated in regenerative medicine and finally cancer stem cells. The medicolegal issues are also discussed in this chapter.",
keywords = "Biomarker, Pluripotent cells, Regenerative medicine, Stem cells",
author = "Alok Mishra and Mukesh Verma",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-804659-3.00021-X",
language = "English (US)",
isbn = "9780128046593",
volume = "1",
pages = "497--505",
booktitle = "Emerging Fields, Animal and Medical Biotechnologies",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Therapeutic aspects of stem cells in regenerative medicine

AU - Mishra, Alok

AU - Verma, Mukesh

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Regenerative medicine is the process of replacing or regenerating human cells, tissues, or organs and establishing normal function. In the last 20 years "stem cell research" has made significant advancement of their fundamental understanding of therapeutic intervention. The different kinds of organ-specific, embryonic, and induced pluripotent stem cells-based therapies offer potentially very strong and promising treatment regimens for contemporary and future medicine. Some of them are even approved and legalized for medical practice by the regulatory bodies of health research, such as US Food and Drug Administration. In the present review, we have compiled the overview of some of the stem cell-based therapies, which are widely linked to important human diseases. Our major aim is to sensitize the readers precisely about therapeutic potentials and application in precision medicine of different kinds of stem cells in disease-specific manner rather than providing the details of the fundamentals of signaling pathways and molecular biology involved in identification and propagation. We have also discussed about the clinically relevant stem cells implicated in regenerative medicine and finally cancer stem cells. The medicolegal issues are also discussed in this chapter.

AB - Regenerative medicine is the process of replacing or regenerating human cells, tissues, or organs and establishing normal function. In the last 20 years "stem cell research" has made significant advancement of their fundamental understanding of therapeutic intervention. The different kinds of organ-specific, embryonic, and induced pluripotent stem cells-based therapies offer potentially very strong and promising treatment regimens for contemporary and future medicine. Some of them are even approved and legalized for medical practice by the regulatory bodies of health research, such as US Food and Drug Administration. In the present review, we have compiled the overview of some of the stem cell-based therapies, which are widely linked to important human diseases. Our major aim is to sensitize the readers precisely about therapeutic potentials and application in precision medicine of different kinds of stem cells in disease-specific manner rather than providing the details of the fundamentals of signaling pathways and molecular biology involved in identification and propagation. We have also discussed about the clinically relevant stem cells implicated in regenerative medicine and finally cancer stem cells. The medicolegal issues are also discussed in this chapter.

KW - Biomarker

KW - Pluripotent cells

KW - Regenerative medicine

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85054408357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054408357&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-804659-3.00021-X

DO - 10.1016/B978-0-12-804659-3.00021-X

M3 - Chapter

AN - SCOPUS:85054408357

SN - 9780128046593

VL - 1

SP - 497

EP - 505

BT - Emerging Fields, Animal and Medical Biotechnologies

PB - Elsevier Inc.

ER -